News
OGEN
--
0.00%
--
Why Did Oragenics Shares Skyrocket Tuesday?
Oragenics Inc. (NYSE: OGEN) shares skyrocketed higher Tuesday after the company entered into a licensing agreement with the National Research Council of Canada to pursue the rapid development of next-generation SARS-CoV-2 vaccines.
Benzinga · 2d ago
SINT, NCTY and INTZ among mid-day movers
Gainers: Intrusion (INTZ) +65%.MOGU (MOGU) +40%.Oragenics (OGEN) +32%.BiondVax Pharmaceuticals (BVXV) +29%.Sintx Technologies (SINT) +23%.Dyadic International (DYAI) +21%.EyeGate Pharmaceuticals (EYEG) +19%.U.S. Physical Therapy (USPH) +18%.ObsEva SA (OBSV...
Seekingalpha · 2d ago
WDAY Stock: The Amazon News That Has Workday Shares Slipping Today
Investor Place · 2d ago
OGEN Stock: The Covid Vaccine News That Has Oragenics Shooting Higher Today
Investor Place · 2d ago
Oragenics Stock Is Trading Higher On Licensing, Material Transfer Pact For Rapid Development Of COVID-19 Vaccine
Benzinga · 2d ago
Oragenics shares soar on licensing agreement to develop COVID-19 vaccines
Oragenics (OGEN) has entered into a licensing agreement with the National Research Council of Canada ((NRC)) to pursue the rapid development of next-generation vaccines against the SARS-CoV-2 virus and its variants.Shares
Seekingalpha · 2d ago
BRIEF-Oragenics Enters Into Licensing Agreement With The National Research Council Of Canada, To Pursue The Rapid Development Of Next-Generation Sars-Cov-2 Vaccines
reuters.com · 2d ago
Oragenics Enters Licensing Agreement With National Research Council Of Canada To Pursue Development Of SARS-CoV-2 Vaccines
Agreement provides Oragenics with antigen expression cell line technology capable of producing spike proteins within six to eight weeks of gene sequence definition Technology includes the ability to engineer vaccine
Benzinga · 2d ago
Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
TAMPA, Fla., July 27, 2021--Oragenics Enters into Licensing Agreement with the National Research Council of Canada to Pursue the Rapid Development of Next-Gen SARS-CoV-2 Vaccines
Business Wire · 2d ago
Oragenics Working With National Research Council of Canada to Accelerate Development of Next-Generation COVID-19 Vaccines; Shares Rise 61%
MT Newswires · 2d ago
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company") announced that the Company's annual meeting of shareholders, on June 30, 2021, at 9:00 a.m. was convened and adjourned, without any business being conducted, due to lack of the required q...
Business Wire · 07/01 11:00
BRIEF-Oragenics Issues Letter To Shareholders
reuters.com · 05/18 11:43
Oragenics Issues Letter to Shareholders
--Highlights Deep Bench Strength Among Management, Board and Advisors in Vaccine Development and in Life Sciences
BusinessWire · 05/18 11:30
10-Q: ORAGENICS INC
(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following information should...
Edgar Online - (EDG = 10Q, 10K) · 05/03 20:14
BRIEF-Oragenics Announce Changes In Management And Board Of Directors
reuters.com · 05/03 12:19
Oragenics Announce Changes in Management and Board of Directors
BusinessWire - BZX · 05/03 11:30
OGEN: COVID-19 Vaccine Candidate Exhibits Protective Immunity in Mice…
By David Bautz, PhD NYSE:OGEN READ THE FULL OGEN RESEARCH REPORT
Benzinga · 04/14 14:31
OGEN: COVID-19 Vaccine Candidate Exhibits Protective Immunity in Mice
By David Bautz, PhD NYSE:OGEN READ THE FULL OGEN RESEARCH REPORT Business Update CoV-2 S-2P Demonstrates Protective Immunity in Mice In February 2021, Oragenics, Inc. (NYSE:OGEN) announced data from the National Institutes of Health (NIH) that demonstrated...
Zacks Small Cap Research · 04/09 15:50
8-K: ORAGENICS INC
Edgar Online - (EDK = 8-Ks/S1/S-4) · 04/01 21:51
Enveric Biosciences, MediciNova leads healthcare gainers; INVO Bioscience, Second Sight Medical Products among major losers
Gainers: Enveric Biosciences ENVB +86%, MediciNova (MNOV) +53%, Artelo Biosciences ARTL +23%, Inari Medical (NARI) +15%.Losers: INVO Bioscience (INVO) -34%, Second Sight Medical Products (EYES) -26%, Sintx Technologies (SINT) -23%, Auris Medical (EARS) -21...
Seekingalpha · 03/10 16:00
Webull provides a variety of real-time OGEN stock news. You can receive the latest news about ORAGENICS through multiple platforms. This information may help you make smarter investment decisions.
About OGEN
Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as an antibiotic, as well as other homolog antibiotic product candidates and AG013 for the treatment of oral mucositis in patients undergoing treatment for cancer. The Company have developed other product such as weight loss candidate, LPT3-04 and SMaRT Replacement Therapy.